CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xian, W.
Right arrow Articles by DiGiovanni, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xian, W.
Right arrow Articles by DiGiovanni, J.

Cell Growth & Differentiation, Vol 6, Issue 11 1447-1455, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice

W Xian, K Kiguchi, A Imamoto, T Rupp, A Zilberstein and J DiGiovanni
Department of Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957, USA.

The present study was designed to further investigate the role of the epidermal growth factor receptor (EGFr) in mouse skin tumor promotion by evaluating the status of the EGFr in tumor promoter-treated mouse epidermis and in mouse skin tumors. Female SENCAR mice received three topical treatments of either the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) or the nonphorbol esters okadaic acid and chrysarobin. Membrane proteins from SENCAR mouse epidermis were isolated 6 h after the last treatment, and the phosphotyrosine content of the EGFr and several potential substrates were examined by Western blot analysis. The results indicated that multiple applications of all three tumor promoters led to an increase in the phosphotyrosine content of the EGFr and also of several lower molecular weight proteins (M(r) approximately 80,000-85,000). Phosphorylation of PLC gamma 1 on tyrosine residues could not be detected in tumor promoter-treated mouse epidermis when the phosphotyrosine content of the EGFr was elevated or in cultured keratinocytes exposed to exogenous EGF. When two tyrosine kinase inhibitors (tyrphostins RG50864 and RG13022) were incorporated into the treatment regimens, the TPA-induced epidermal hyperplasia and cell proliferation were effectively blocked, and the TPA-stimulated EGFr tyrosine phosphorylation was significantly reduced. Examination of the phosphotyrosine content of epidermal membrane proteins isolated from skin papillomas revealed that the EGFr also had elevated phosphotyrosine levels. These results demonstrate that multiple topical treatments with both phorbol ester and nonphorbol ester tumor promoters lead to activation of the EGFr tyrosine kinase in mouse epidermis. In addition, these data suggest that signaling through the EGFr pathway plays an important role in the tumor promotion stage of multistage carcinogenesis in mouse skin.


This article has been cited by other articles:


Home page
Cancer Prev ResHome page
T. Moore, L. Beltran, S. Carbajal, S. D. Hursting, and J. DiGiovanni
Energy Balance Modulates Mouse Skin Tumor Promotion through Altered IGF-1R and EGFR Crosstalk
Cancer Prevention Research, October 1, 2012; 5(10): 1236 - 1246.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prev ResHome page
K. Kiguchi, T. Kitamura, T. Moore, M. Rumi, H.-C. Chang, D. Treece, L. Ruffino, K. Connolly, and J. DiGiovanni
Dual Inhibition of Both the Epidermal Growth Factor Receptor and erbB2 Effectively Inhibits the Promotion of Skin Tumors during Two-Stage Carcinogenesis
Cancer Prevention Research, August 1, 2010; 3(8): 940 - 952.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. D'Alessio, L. Gerasi, and F. Blasi
uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro
J. Cell Sci., December 1, 2008; 121(23): 3922 - 3932.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Moore, S. Carbajal, L. Beltran, S. N. Perkins, S. Yakar, D. LeRoith, S. D. Hursting, and J. DiGiovanni
Reduced Susceptibility to Two-Stage Skin Carcinogenesis in Mice with Low Circulating Insulin-Like Growth Factor I Levels
Cancer Res., May 15, 2008; 68(10): 3680 - 3688.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Lu, O. Rho, E. Wilker, L. Beltran, and J. DiGiovanni
Activation of Epidermal Akt by Diverse Mouse Skin Tumor Promoters
Mol. Cancer Res., December 1, 2007; 5(12): 1342 - 1352.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Hara, Y. Saito, T. Hirai, K. Nakamura, K. Nakao, M. Katsuki, and K. Chida
Deficiency of Protein Kinase C{alpha} in Mice Results in Impairment of Epidermal Hyperplasia and Enhancement of Tumor Formation in Two-Stage Skin Carcinogenesis
Cancer Res., August 15, 2005; 65(16): 7356 - 7362.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. S. Chan, S. Carbajal, K. Kiguchi, J. Clifford, S. Sano, and J. DiGiovanni
Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis
Cancer Res., April 1, 2004; 64(7): 2382 - 2389.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
N. Chen, W.-Y. Ma, Q.-B. She, E. Wu, G. Liu, A. M. Bode, and Z. Dong
Transactivation of the Epidermal Growth Factor Receptor Is Involved in 12-O-Tetradecanoylphorbol-13-acetate-induced Signal Transduction
J. Biol. Chem., December 14, 2001; 276(50): 46722 - 46728.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. D. Woodworth, D. Gaiotti, E. Michael, L. Hansen, and M. Nees
Targeted Disruption of the Epidermal Growth Factor Receptor Inhibits Development of Papillomas and Carcinomas from Human Papillomavirus-immortalized Keratinocytes
Cancer Res., August 1, 2000; 60(16): 4397 - 4402.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
L. A. Hansen, R. L. Woodson II, S. Holbus, K. Strain, Y.-C. Lo, and S. H. Yuspa
The Epidermal Growth Factor Receptor Is Required to Maintain the Proliferative Population in the Basal Compartment of Epidermal Tumors
Cancer Res., July 1, 2000; 60(13): 3328 - 3332.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
Q. Li, S. M. Vaingankar, H. M. Green, and M. Martins-Green
Activation of the 9E3/cCAF Chemokine by Phorbol Esters Occurs via Multiple Signal Transduction Pathways That Converge to MEK1/ERK2 and Activate the Elk1 Transcription Factor
J. Biol. Chem., May 28, 1999; 274(22): 15454 - 15465.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Lahiri-Chatterjee, S. K. Katiyar, R. R. Mohan, and R. Agarwal
A Flavonoid Antioxidant, Silymarin, Affords Exceptionally High Protection against Tumor Promotion in the SENCAR Mouse Skin Tumorigenesis Model
Cancer Res., February 1, 1999; 59(3): 622 - 632.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. P. Soltoff
Related Adhesion Focal Tyrosine Kinase and the Epidermal Growth Factor Receptor Mediate the Stimulation of Mitogen-activated Protein Kinase by the G-protein-coupled P2Y2 Receptor: PHORBOL ESTER OR [Ca2+] i ELEVATION CAN SUBSTITUTE FOR RECEPTOR ACTIVATION
J. Biol. Chem., September 4, 1998; 273(36): 23110 - 23117.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.